Thermodilution-Based Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance: Quantification of Microvascular (Dys)Function?


Journal

Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826

Informations de publication

Date de publication:
2020
Historique:
received: 12 05 2020
revised: 09 10 2020
accepted: 23 10 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 24 4 2021
Statut: epublish

Résumé

During the last two decades, there has been a sharp increase in both interest and knowledge about the coronary microcirculation. Since these small vessels are not visible by the human eye, physiologic measurements should be used to characterize their function. The invasive methods presently used (coronary flow reserve (CFR) and index of microvascular resistance (IMR)) are operator-dependent and mandate the use of adenosine to induce hyperemia. In recent years, a new thermodilution-based method for measurement of absolute coronary blood flow and microvascular resistance has been proposed and initial procedural problems have been overcome. Presently, the technique is easy to perform using the Rayflow infusion catheter and the Coroventis software. The method is accurate, reproducible, and completely operator-independent. This method has been validated noninvasively against the current golden standard for flow assessment: Positron Emission Tomography-Computed Tomography (PET-CT). In addition, absolute flow and resistance measurements have proved to be safe, both periprocedurally and at long-term follow-up. With an increasing number of studies being performed, this method has great potential for better understanding and quantification of microvascular disease.

Identifiants

pubmed: 33293902
doi: 10.1155/2020/5024971
pmc: PMC7688370
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5024971

Informations de copyright

Copyright © 2020 Daniëlle C. J. Keulards et al.

Déclaration de conflit d'intérêts

Nico H. J. Pijls reports institutional grant from Abbott and Hexacath, consulting for Abbott and Opsens, minor equities in Philips, GE, ASML, and Heartflow, and consulting for GE and personal fees for GE. All other authors report no conflicts of interest.

Références

Int J Cardiol. 2016 Jan 1;202:305-10
pubmed: 26418191
EuroIntervention. 2018 Aug 03;14(5):e588-e589
pubmed: 29175771
EuroIntervention. 2020 Feb 25;:
pubmed: 32091402
J Am Coll Cardiol. 2007 Dec 11;50(24):2294-304
pubmed: 18068038
Eur Heart J. 2019 Jul 21;40(28):2350-2359
pubmed: 31327012
Circ Cardiovasc Interv. 2017 Apr;10(4):
pubmed: 28400462
Heart. 2004 Apr;90(4):457-63
pubmed: 15020531
Circ Cardiovasc Interv. 2018 Mar;11(3):e006194
pubmed: 29870386
Circulation. 2003 Jul 1;107(25):3129-32
pubmed: 12821539
Cardiovasc Revasc Med. 2016 Mar;17(2):81-7
pubmed: 26905054
J Am Heart Assoc. 2020 May 5;9(9):e015669
pubmed: 32316813
J Am Coll Cardiol. 2018 Nov 27;72(21):2625-2641
pubmed: 30466521
EuroIntervention. 2016 Aug 20;12(6):701-7
pubmed: 27542781
J Am Heart Assoc. 2020 Aug 4;9(15):e015793
pubmed: 32689859
EuroIntervention. 2020 Oct 06;:
pubmed: 33016881
Heart. 2020 Oct;106(19):1489-1494
pubmed: 32471907
Eur Heart J Qual Care Clin Outcomes. 2015 Jul 1;1(1):23-30
pubmed: 29474572
Clin Hemorheol Microcirc. 2019;71(3):299-310
pubmed: 30103305
Eur Heart J. 2020 Oct 1;41(37):3504-3520
pubmed: 32626906
N Engl J Med. 2010 Mar 11;362(10):886-95
pubmed: 20220183
J Am Coll Cardiol. 2008 Feb 5;51(5):560-5
pubmed: 18237685
Circulation. 1990 Feb;81(2):482-90
pubmed: 2105173

Auteurs

Daniëlle C J Keulards (DCJ)

Catharina Hospital, Eindhoven, Netherlands.

Mohamed El Farissi (M)

Catharina Hospital, Eindhoven, Netherlands.

Pim A L Tonino (PAL)

Catharina Hospital, Eindhoven, Netherlands.
Eindhoven University of Technology, 5612 AZ Eindhoven, Netherlands.

Koen Teeuwen (K)

Catharina Hospital, Eindhoven, Netherlands.

Pieter-Jan Vlaar (PJ)

Catharina Hospital, Eindhoven, Netherlands.

Eduard van Hagen (E)

Catharina Hospital, Eindhoven, Netherlands.

Inge F Wijnbergen (IF)

Catharina Hospital, Eindhoven, Netherlands.

Annemiek de Vos (A)

Catharina Hospital, Eindhoven, Netherlands.

Guus R G Brueren (GRG)

Catharina Hospital, Eindhoven, Netherlands.

Marcel Van't Veer (M)

Catharina Hospital, Eindhoven, Netherlands.
Eindhoven University of Technology, 5612 AZ Eindhoven, Netherlands.

Nico H J Pijls (NHJ)

Catharina Hospital, Eindhoven, Netherlands.
Eindhoven University of Technology, 5612 AZ Eindhoven, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH